Indo-German Collaboration Delivers Novel Diabetic Foot Ulcer Treatment
Executive Summary
Centaur-CytoTools introduces novel topical treatment for diabetic foot ulcers in India, for which they see limited direct competition and hope to change the way the difficult-to-treat diabetes complication is managed. Phase III studies are ongoing in Europe.
You may also be interested in...
CytoTools pins hopes on wound healing agent DermaPro
CytoTools, the holding company of DermaTools Biotech, has a lot riding on DermaTools' wound healing agent DermaPro (diperoxochloric acid), the latter's first product which is now heading towards potential commercialisation.
What’s Next At Dr Reddy’s: Biologics CDMO, Cell And Gene Therapy Push
Indian firms are getting their act together in areas like cell and gene therapy, with Dr Reddy’s aiming big and readying a facility alongside an alliance with a Chinese firm for a CAR-T therapy. The company is also doubling down in contract development and manufacturing, with an eye on opportunities in biologics.
Amgen, J&J, Takeda R&D Heads On The Era Of Human Data, Treating Disease Earlier
Big pharma R&D leaders discuss the confluence of technology and biotech driving insights into biology and how industry is doing in terms of identifying patients earlier in disease.